EMAIL THIS PAGE TO A FRIEND

No to shinkei = Brain and nerve

[P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid].


PMID 7126379

Abstract

Using reversed-phase high-performance liquid chromatography and electrochemical detection with a rapid one-step purification on Sephadex G-10 column, we have developed a sensitive technique to measure p-hydroxyphenylacetic acid (PHPA), the oxidatively deaminated metabolite of p-tyramine, in cerebrospinal fluid (CSF). The method has been shown to offer simplicity, high sensitivity and low cost for the analysis of PHPA. By using this method PHPA can be measured concurrently with the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), in small amounts of CSF (0.5 ml or less). The concentrations of PHPA ranged 4.2 to 17.0 ng/ml with a mean value of 7.8 ng/ml+/-1.1 SEM in lumbar CSF of non-neurological control patients. PHPA value is consistent with the results of earlier studies using different methods. PHPA concentrations in both schizophrenic (4.7+/-0.6 ng/ml, n=11) and epileptic patients (5.8+/-0.4 ng/ml, n=28) were significantly lower than those in control patients. A concentration gradient of PHPA was found along the ventricular-lumbar axis. Probenecid markedly increased PHPA in lumbar CSF. These observations suggest that PHPA in lumbar CSF is derived at least in part from the brain and eliminated from CSF by a probenecid-sensitive transport mechanism. There was a significant correlation between PHPA and HVA concentrations in CSF. This is an interesting finding since a reciprocal relationship between dopamine turnover and p-tyramine concentrations has been found in the striatum of experimental animals. A number of recent studies suggest that p-tyramine may act as neurotransmitter or neuromodulator in specific neuronal systems. The present method should be useful in clinical investigations to clarify a functional role of p-tyramine in the brain.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

H50004
4-Hydroxyphenylacetic acid, 98%
C8H8O3
01905
Adenosine 5′-diphosphate, ≥95% (HPLC)
C10H15N5O10P2
G1001
D-Glutamic acid, ≥99% (TLC)
C5H9NO4
67419 Glycine 1 M solution
A0884
L-Asparagine, ≥98% (HPLC)
C4H8N2O3
A4159
L-Asparagine, BioReagent, suitable for cell culture, suitable for insect cell culture
C4H8N2O3
51363
L-Asparagine, certified reference material, TraceCERT®
C4H8N2O3
PHR1104
L-Aspartic acid, Pharmaceutical Secondary Standard; Certified Reference Material
C4H7NO4
51572
L-Aspartic acid, certified reference material, TraceCERT®
C4H7NO4
G2150
L-Glutamine solution, 200 mM, Hybri-Max, sterile-filtered, suitable for hybridoma
54763
L-Serine, certified reference material, TraceCERT®
C3H7NO3
PHR1103
L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material
C3H7NO3
V4638
L-Valine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C5H11NO2
50848
L-Valine, certified reference material, TraceCERT®
C5H11NO2
W527718
L-Valine, FCC
C5H11NO2
59202C
L-Glutamine Solution 200 mM, 29.23 mg/mL in saline, solution, suitable for cell culture
PHR1172
L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material
C5H11NO2
00920
N-Acetyl-L-aspartic acid, ≥99.0% (T)
C6H9NO5
A5930
N-Acetyl-Asp-Glu, ≥97% (TLC), powder
C11H16N2O8